New Addition to InspireMD's Board: Leadership with Experience
InspireMD Welcomes Raymond W. Cohen to the Board
InspireMD, Inc. (NASDAQ: NSPR), renowned for its innovative CGuard® Prime carotid stent system, has recently announced a significant development within its leadership team. The Company is thrilled to welcome Raymond W. Cohen to its Board of Directors. With over four decades of experience in the medical technology sector, Mr. Cohen brings a wealth of knowledge and a proven track record of success in scaling operations and enhancing shareholder value through strategic initiatives and market leadership.
Ray Cohen's Impressive Background
Raymond W. Cohen's reputation in the medical field is well earned. As the CEO and a co-founder of Axonics, Inc., he guided the company through a successful public offering in late 2018, ultimately leading to its impressive $3.7 billion acquisition by Boston Scientific in November 2024. This milestone was a testament to Axonics' rapid growth, having been recognized as the fastest-growing company across the Americas by prestigious organizations like Deloitte and the Financial Times in 2021.
Strategic Vision and Contributions
The qualifications that Mr. Cohen brings to InspireMD are noteworthy. Prior to joining InspireMD, he served as Chairman of SoniVie Ltd., a clinical-stage company focused on hypertension treatments, which was also acquired by Boston Scientific. His experience extends to serving as an independent director for Kestra Medical (NASDAQ: KMTS) and Spectrum Vascular Inc., alongside leadership roles at Nalu Medical and Tulavi, Inc.
Inspiring Growth and Innovation at InspireMD
As InspireMD prepares for the commercial launch of its advanced CGuard Prime stent system following recent PMA approval, Mr. Cohen's operational acumen and strategic insights are expected to be invaluable. Marvin Slosman, CEO of InspireMD, expressed excitement about Mr. Cohen’s addition to the team, highlighting how his extensive experience will contribute to the company’s mission of delivering innovative stroke prevention solutions. Slosman stated, “Ray’s insights and perspectives will strengthen our execution and enhance our long-term value-creation strategy.”
The Future of InspireMD with Raymond Cohen
Mr. Cohen is keen to leverage his experiences in scaling high-growth MedTech businesses to assist InspireMD in capturing market share effectively. He emphasized that the CGuard Prime stent system stands out as a premier innovation in the carotid stenting industry. His strong belief in the company’s singular focus, entrepreneurial approach, and commitment to clinical excellence positions InspireMD to lead the U.S. carotid stent market. “I look forward to working closely with Marvin and the team,” he noted with enthusiasm.
About InspireMD, Inc.
InspireMD is dedicated to becoming the gold standard in carotid stenting through its proprietary MicroNet™ mesh technology. With a focus on delivering superior acute results and long-term, stroke-free outcomes, InspireMD seeks to provide patients and healthcare providers the best tools available for stroke prevention. The Company's common stock trades under the ticker symbol NSPR on NASDAQ. To stay updated with the latest company information, investors and interested parties can visit InspireMD's official website.
Frequently Asked Questions
1. Who is Raymond W. Cohen?
Raymond W. Cohen is the newly appointed member of InspireMD's Board of Directors, bringing over 40 years of leadership in medical technology.
2. What is InspireMD known for?
InspireMD is known for its CGuard® Prime carotid stent system which is designed for stroke prevention.
3. What recent achievement did InspireMD announce?
InspireMD announced a recent PMA approval of its CGuard Prime stent, setting the stage for its commercial launch.
4. Why is Mr. Cohen's appointment significant?
His extensive background in scaling MedTech companies is expected to strengthen InspireMD's strategic execution and market presence.
5. How can investors learn more about InspireMD?
Investors can find critical information on InspireMD's official website, where updates and other announcements are regularly posted.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.